EULAR/LinkedIn
Dec 18, 2025, 13:16
New Score Quantifying Disease Activity in Patients With Antiphospholipid Syndrome – EULAR
EULAR – European Alliance of Associations for Rheumatology shared a post on LinkedIn:
“NEWS ALERT!
EULAR has developed a new score that quantifies the level of disease activity in people with antiphospholipid syndrome (APS). A key step forward that promises to advance research and improve symptom tracking, both in clinical trials and everyday practice.
Read the full EULAR Press Release here.”
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Oct 11, 2025, 06:44The Global IVF Market Is Set to Reach $65B by 2032 – Meddilink
-
Jan 14, 2026, 17:27Giulia Zamagni: Critical Gaps in Machine Learning Models for Fetal Growth Restriction
-
Jan 14, 2026, 17:25Structured Multidisciplinary Pathways for Endometriosis – Fondation Endométriose
-
Jan 14, 2026, 17:23Daniel Roshan: Maternal Nail Polish Use and Potential Fetal Exposure
-
Jan 14, 2026, 17:21Rethinking Soy for Women With Endometriosis – Fertility Plus
-
Jan 14, 2026, 17:19Leili Mohebnasab: Understanding Placental Health Through Epigenetics
-
Jan 14, 2026, 17:17High Estradiol and Placental Pathology in Fresh IVF Pregnancies – Fertility and Sterility
-
Jan 12, 2026, 16:03New Insights Into Estrogen Receptor Alpha Regulation in the Endometrium – Fertility and Sterility
-
Jan 12, 2026, 15:37From Innovation to Practice: Standards for Embryo Diagnostic Trials – Fertility and Sterility
-
Jan 12, 2026, 14:47HFEA Updates Choose a Fertility Clinic Tool to Improve Success Reporting